Lofarma Deutschland GmbH
Pharmaceutical Companies · Viersen
Lofarma Deutschland GmbH is a pharmaceutical company based in Viersen, North Rhine-Westphalia, Germany. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Lofarma Deutschland GmbH – Address & Contact
Lofarma Deutschland GmbH Overview
Lofarma Deutschland GmbH is a pharmaceutical company based in Viersen, Nordrhein-Westfalen. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Activities & Products
Pharmaceutical companies such as Lofarma Deutschland GmbH develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).
Location & Contact
Lofarma Deutschland GmbH can be reached at the following address: Hanns-Martin-Schleyer-Str. 26, 47877 Viersen – Phone: 02154888720. For current information and enquiries, please contact the company directly.
More information: Pharmaunternehmen in Nordrhein-Westfalen or all Pharmaunternehmen in Germany on Sanoliste.
Pharmazeutische Regulierung in Deutschland
Pharmaceutical companies such as Lofarma Deutschland GmbH are subject to one of the world's most stringent regulatory frameworks in Germany. The German Medicinal Products Act (AMG) governs the authorisation, manufacturing, distribution and monitoring of medicinal products. Market authorisation for new active substances falls under the responsibility of either the Federal Institute for Drugs and Medical Devices (BfArM) or the European Medicines Agency (EMA), depending on whether a national or centralised authorisation is sought.
Arzneimittelversorgung & Marktumfeld
With a revenue volume exceeding 50 billion euros, the German pharmaceutical market is one of the largest in Europe. Lofarma Deutschland GmbH, based in Viersen, is part of this market. The supply chain from manufacturer through wholesaler to pharmacy is governed by Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP). Since the entry into force of the Act for Greater Safety in the Medicinal Products Supply (GSAV), stricter requirements for the traceability of medicinal products also apply.
Pharmastandort Nordrhein-Westfalen
Nordrhein-Westfalen is a significant pharmaceutical location in Germany. Companies such as Lofarma Deutschland GmbH benefit from proximity to research institutions, university hospitals and well-developed infrastructure. The industry employs over 140,000 people in Germany and invests billions annually in research and development.
Frequently asked questions about Lofarma Deutschland GmbH
What does Lofarma Deutschland GmbH do?
Lofarma Deutschland GmbH hat sich on the Allergietherapie spezialisiert. Sie develops spezifische Immuntherapeutika, at Heuschnupfen and allrgischem Asthma. Sie develops nasale Hyposensibilisierung, Nickeldesensibilisierung and diagnostische Tests and chemisch modifizierte Allergene for eine Immuntherapie. Ihre Mittel offers sie als Sublingualtabletten, als Sublingualtropfen and als subkutane Spritzen an.
What medicines does Lofarma Deutschland GmbH manufacture?
Lofarma Deutschland GmbH is a pharmaceutical company in Viersen. Einleitung Lofarma Deutschland GmbH is ein renommiertes Pharmaundernehmen, the sich on the manufacturing of productsn for the Diagnose and Therapie of Allergien spezialisiert ha Alle in Germany zugelassenen medicines are in the medicines-Datenbank des BfArM recherchierbar.
How are medicines approved in Germany?
Neue medicines benötigen vor dem Inverkehrbringen eine Zulassung durch the BfArM (national) or the EMA (europaweit). Der Zulassungsprozess umfasst the Prüfung of quality, Wirksamkeit and Unbedenklichkeit on Basis präklinischer and klinischer Stuthen. Die Nutzenbewertung after § 35a SGB V entscheidet about the Erstattung durch the gesetzlichen Krankenkassen.
What does GMP mean in pharmaceutical production?
GMP (Good Manufacturing Practice) bezeichnet the Gute manufacturingspraxis – ein System of qualitysstandards, the sicherstellt, thes medicines gleichbleibend after den gefortheten qualitysnormen hergestellt and geprüft are. Die GMP-Richtlinien are in the EU durch den EudraLex Volume 4 definiert.
Lofarma Deutschland GmbH on social media
More Pharmaceutical Companies in Viersen
Pharmaceutical Companies in Germany
Related areas in healthcare
Pharmaceutical Companies in Nordrhein-Westfalen
All Pharmaceutical Companies in Nordrhein-Westfalen on Sanoliste — or discover all categories by federal state.